Nanjing Hicin Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 265.11 million compared to CNY 313.91 million a year ago. Revenue was CNY 267.58 million compared to CNY 316.9 million a year ago.

Net income was CNY 17.72 million compared to CNY 21.14 million a year ago. Basic earnings per share from continuing operations was CNY 0.1477 compared to CNY 0.1761 a year ago. Diluted earnings per share from continuing operations was CNY 0.1477 compared to CNY 0.1761 a year ago.